Crescita Therapeutics Inc. (TSX:CTX)

Canada · Delayed Price · Currency is CAD

0.4800

+0.0100 (2.13%)

Mar 2, 2026, 11:37 AM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Licensing & Royalties	1.25M	2.03M	1.80M	3.97M	7.22M
Licensing & Royalties Growth	-38.37%	12.78%	-54.63%	-45.09%	-40.09%
Commercial Skincare	11.44M	10.44M	8.02M	7.47M	6.70M
Commercial Skincare Growth	9.58%	30.14%	7.40%	11.41%	-11.79%
Manufacturing and Services	6.89M	5.05M	13.70M	5.33M	1.71M
Manufacturing and Services Growth	36.36%	-63.13%	156.95%	211.51%	-36.07%
Total	19.58M	17.52M	23.53M	16.77M	15.64M
Total Growth	11.75%	-25.52%	40.29%	7.22%	-29.98%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Canada	11.86M	11.73M	9.79M	9.63M	12.62M
Canada Growth	1.11%	19.74%	1.66%	-23.69%	-1.08%
United States	5.00M	4.18M	12.14M	4.75M	1.51M
United States Growth	19.80%	-65.58%	155.47%	215.20%	-38.01%
Rest of The World (ROW)	2.72M	1.62M	1.60M	2.39M	1.51M
Rest of The World (ROW) Growth	67.96%	1.38%	-33.05%	57.97%	-78.86%
Total	19.58M	17.52M	23.53M	16.77M	15.64M
Total Growth	11.75%	-25.52%	40.29%	7.22%	-29.98%

Source: S&P Global Market Intelligence.